Sep 26, 2013
1:100
For every 100 shares held, investors received 1.
The split itself did not change the total investment value.
Iovance Biotherapeutics, Inc. (FRA:2LB) operates in the Biotechnology industry.
Iovance Biotherapeutics, Inc. company overviewIovance Biotherapeutics, Inc.'s most recent stock split was on September 26, 2013. It was a 1-for-100 reverse split, so shareholders received 1 share for every 100 they held.
Iovance Biotherapeutics, Inc. (FRA:2LB) has split its stock 2 times: a 24-for-1 split on April 6, 2010 and a 1-for-100 reverse split on September 26, 2013.
Iovance Biotherapeutics, Inc. has split its stock 2 times. This history records 2 splits between April 6, 2010 and September 26, 2013.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Iovance Biotherapeutics, Inc.'s 1-for-100 reverse split on September 26, 2013, every 100 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Iovance Biotherapeutics, Inc. has not announced a new split in our records. Its most recent split was on September 26, 2013, 13 years ago. Companies announce splits in advance, and any new FRA:2LB split will appear on this page.